52 evolution "https:" "https:" "https:" "https:" "https:" "https:" positions at Nature Careers in Germany
Sort by
Refine Your Search
-
biology and immunology. They will research the role of the tumor microenvironment in tumor progression and the development of therapy resistance in solid tumors in the thorax. Of particular interest is
-
European Regional Development Fund (ERDF). The period of employment is governed by § 2 (2) Fixed Term Research Contracts Act (Wissenschaftszeitvertragsgesetz - WissZeitVG). Tasks: Development of an automated
-
the development of the faculty's newly created research cluster “Biotic Interactions in the Anthropocene” (https://go.ur.de/biotic-interactions) are desirable. It is expected that the professorship will strengthen
-
Fluent English (spoken and written) Publications at top-tier computer vision conference or journals is a plus Experience with open-source software development is a plus We offer A clear research topic as
-
, or quantitative behavioral biology etc. The position is intended to strengthen the faculty’s research focus on “Biotic Interactions in the Anthropocene” (https://go.ur.de/biotic-interactions), ideally collaborating
-
are able and willing to teach in both English and German are preferred. FAU offers career development, mentoring, and an attractive initial research budget. Based on international standards and transparent
-
Research Centre (CRC) 1450 “inSight – Multiscale imaging of organ-specific inflammation” (https://www.uni-muenster.de/CRC-inSight) The project is based in the research group of Prof. Dr. Kerstin Steinbrink
-
Job Advertisement HKI-52/2025 At the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI): https://www.leibniz-hki.de/en/#, we research the pathobiology
-
record in the development and application of innovative approaches for the preclinical and clinical advancement of cellular immunotherapies. A primary focus should be on the treatment of oncological
-
the development of scalable software tools and pipelines, potentially leveraging GPU/FPGA accelerators. Our aim is to build next-generation molecular atlases for chronic diseases and to improve patient